Mild inflammation impairs acute intermittent hypoxia-induced phrenic long-term facilitation by a spinal

Alexandria B Marciante1, Gordon S Mitchell1

  • 1Breathing Research and Therapeutics Center, Department of Physical Therapy & McKnight Brain Institute, University of Florida, Gainesville, Florida, United States.

Insights

Mild inflammation impairs respiratory motor plasticity (phrenic long-term facilitation) by increasing spinal adenosine and activating adenosine 2A receptors. Blocking these receptors restores plasticity, offering potential therapeutic strategies for neuroinflammatory conditions.

Area of Science:

  • Neuroscience
  • Respiratory Physiology
  • Inflammation Research

Background:

  • Neuroinflammation disrupts neuroplasticity, affecting motor control.
  • Moderate acute intermittent hypoxia (mAIH) normally enhances phrenic long-term facilitation (pLTF), a measure of respiratory motor plasticity.
  • Mild inflammation, induced by lipopolysaccharide (LPS), abolishes mAIH-induced pLTF through unknown mechanisms.

Purpose of the Study:

  • To investigate if spinal adenosine accumulation and adenosine 2A (A2A) receptor activation mediate the impairing effects of LPS on mAIH-induced pLTF.
  • To test the hypothesis that blocking spinal A2A receptors can restore mAIH-induced pLTF in the presence of inflammation.

Main Methods:

  • Adult male Sprague Dawley rats were administered LPS (100 µg/kg, ip) or saline.
  • Adenosine levels were measured in cervical spinal cord segments (C3-C5) 24 hours post-injection.
  • Intrathecal administration of an A2A receptor inhibitor (MSX-3, 10 µM) was performed before mAIH exposure.
  • Phrenic long-term facilitation (pLTF) was assessed following mAIH.

Main Results:

  • LPS injection significantly increased adenosine levels in the phrenic motor nucleus-containing spinal segments.
  • Inhibition of cervical spinal A2A receptors with MSX-3 restored mAIH-induced pLTF in LPS-treated rats.
  • MSX-3 administration alone enhanced pLTF in control (saline-treated) rats, but not in LPS-treated rats, indicating A2A receptor involvement in LPS's effect.

Conclusions:

  • Inflammation abolishes mAIH-induced pLTF via a mechanism requiring increased spinal adenosine and subsequent A2A receptor activation.
  • Targeting spinal adenosine A2A receptors may counteract the negative effects of neuroinflammation on respiratory motor plasticity.
  • This finding is relevant for therapeutic strategies using mAIH in conditions like spinal cord injury and ALS, where neuroinflammation is present.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
304
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
242
Other Factors Affecting Respiration Centers01:17

Other Factors Affecting Respiration Centers

Breathing is primarily an involuntary activity regulated by the brainstem respiratory centers. However, it can also be consciously controlled, allowing us to hold our breath or take deeper breaths when needed. This voluntary control is facilitated by the cerebral motor cortex, which bypasses the medullary centers to stimulate the respiratory muscles directly.
However, the ability to hold one's breath voluntarily is not limitless. When the CO2 concentration in the blood reaches a critical...
929
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
417
Physiological Control of Respiration01:23

Physiological Control of Respiration

Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
2.2K
Physiology of Respiration II: Neurogenic Control of Respiration01:22

Physiology of Respiration II: Neurogenic Control of Respiration

The neurogenic control of respiration coordinates various neural networks and pathways to regulate breathing rate and depth, meeting the body's oxygen and carbon dioxide exchange requirements. This system adapts to physiological and environmental conditions, ensuring optimal breathing patterns.
Central Control
The brainstem is the primary site of central control, hosting respiratory centers:
735